Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti IL-6R”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableUnknownNCT05925790
What this trial is testing

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels

Who this might be right for
Pericarditis
ASST Fatebenefratelli Sacco 146
Large-scale testing (Phase 3)Enrolling By InvitationNCT06726096
What this trial is testing

Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Anti IL-6R
Beijing VDJBio Co., LTD. 615
Large-scale testing (Phase 3)Study completedNCT04227366
What this trial is testing

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biocad 154
Not applicableUnknownNCT06442709
What this trial is testing

Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Hospital of Nantong University 100
Not applicableUnknownNCT05045001
What this trial is testing

Pharmacogenetic Studies on Anti-IL-6 Receptor Monoclonal Antibodies on the Treatment of Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisIdiopathic Juvenile ArthritisGiant Cell Arteritis+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 140
Testing effectiveness (Phase 2)Ended earlyNCT04322773
What this trial is testing

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure

Who this might be right for
Corona Virus Disease
Marius Henriksen 20
Testing effectiveness (Phase 2)Study completedNCT01284569
What this trial is testing

Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing

Anti-IL-6R mAb Injection in Patients With iMCD

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Not applicableUnknownNCT04505982
What this trial is testing

Anti IL6R Reduce Complement Serum Level in Rheumatoid Arthritis Patients: Facts and Implications

Who this might be right for
Rheumatoid Polyarthritis
BADOT, Valerie 35
Early research (Phase 1)Study completedNCT06021574
What this trial is testing

A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody

Who this might be right for
Healthy
The Affiliated Hospital of Qingdao University 40
Large-scale testing (Phase 3)Study completedNCT02057250
What this trial is testing

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Who this might be right for
RA
Sanofi 217
Large-scale testing (Phase 3)Active Not RecruitingNCT05800327
What this trial is testing

A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biocad 261
Large-scale testing (Phase 3)Study completedNCT06048224
What this trial is testing

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Zhejiang Hisun Pharmaceutical Co. Ltd. 669